8/18/2022Kidney Disease Drugs A Hot Spot for July In-licensing (PharmaDJ)

8/18/2022Vision 2028: How China Could Impact the Global Biopharma Industry (McK...

8/17/2022AbbVie to Discontinue Phase 1 Trial for I-Mab's Anti-CD47 Therapy for ...

8/17/2022Review of Chinese Retail Drug Sales in Q1/2022

8/17/2022Huadong Completes Acquisition of 35% Stake in Heidelberg Pharma

8/17/2022Menarini and SciClone Enter License Pact for Vaborem in China for An...

8/17/2022CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines M10:...

8/17/2022WuXi STA Breaks Ground for 2nd Drug Manufacturing Facility in the U.S.

8/15/2022Chinese Pharma Cos Reportedly Slashing Headcount as Performance Dims

8/12/2022Zai Lab Throws the Towel in CD47 Race and Decides to 'Deprioritize' I...

8/12/2022Janssen Licences TESSA Technology from WuXi ATU

8/12/2022Recent Official and Executive Moves

8/11/2022Snapshot of BMI System Financial Performance in H1/2022

8/11/2022IQVIA: Overall Chinese Pharma Market Up 8.3% in 2021

8/10/2022Chiesi Group Continues China Business Expansion: China Daily

8/9/2022BioDuro-Sundia and X-Chem Enter Partnership to Launch DEL Services in ...

8/9/2022NHSA Introduces the Uniform Coding Rules and Methods for BMI Designate...

8/9/2022NHSA Cites Three Major Pharma Manufacturers for Artificially Hiking AP...

8/9/2022Ophthalmology A New Opportunity for Biotechs in China (PharmaDJ)

8/9/2022Analysis of Regulations for Approval of Digital Therapeutics in China

8/8/2022Hansoh and TiumBio Enter $164M Licensing Pact for TU2670 in China

8/8/2022AstraZeneca and Wuxi Biologics Tie Up to Make Preventive Covid-19 Jab ...

8/5/2022Recent Executive Moves

8/5/2022Bird's Eye View of Chinese Pharma Now: A Mixed Bag of Mostly Negative ...

8/2/2022China Slaps MAH System on Vaccine Manufacturing to Limit Newcomers (Ph...

7/29/2022Drug R&D and Approvals in China – June Update on YouTube (PharmCube)

7/29/2022Pricing and Market Access in China: How Medtechs Can Succeed

7/29/2022CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines ICH ...

7/29/2022NHC and SATCM Issues Notice to Further Strengthen Drug Safety Manageme...

7/29/2022Recent Official and Executive Moves

Page:62/356 Total number of articles:10671: [First][<<] [60] [61] [62] [63] [64] [>>] [End]